Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannes Alber

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
The New England Journal of Medicine|November 18, 2010
Drug-eluting versus bare-metal stents in large coronary arteriesChristoph Kaiser, Soeren Galatius, Paul Erne, et al.
The American Journal of Cardiology|November 7, 2017
In-Hospital Outcome Comparing Bivalirudin to Heparin in Real-World Primary Percutaneous Coronary InterventionMatthias Hasun, Jakob Dörler, Michael Edlinger, et al.
Wiener Klinische Wochenschrift|February 20, 2020
Heart failure disease management programs in Austria 2019 : A systematic survey of the Heart Failure Working Group and the Working Group for Cardiological Assistance and Care Personnel of the Austrian Society of CardiologyGerhard Poelzl, Bettina Fetz, Johann Altenberger, et al.
American Heart Journal|August 9, 2024
A randomized comparison of the treatment sequence of percutaneous coronary intervention and transcatheter aortic valve implantation: Rationale and design of the TAVI PCI trialBarbara E Stähli, Axel Linke, Dirk Westermann, et al.
Journal of Clinical Medicine|October 14, 2022
Dutogliptin in Combination with Filgrastim in Early Recovery Post-Myocardial Infarction-The REC-DUT-002 TrialDirk von Lewinski, Martin Benedikt, Hannes Alber, et al.
International Journal of Cardiology|July 16, 2013
Heart rate at discharge and long-term prognosis following percutaneous coronary intervention in stable and acute coronary syndromes--results from the BASKET PROVE trialMagnus Thorsten Jensen, Christoph Kaiser, Karl Erik Sandsten, et al.
Plos One|January 16, 2019
Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE IIRaban V Jeger, Matthias Pfisterer, Deborah R Vogt, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 19, 2024
Impact of empagliflozin on cardiac structure and function assessed by echocardiography after myocardial infarction: a post-hoc sub-analysis of the emmy trialNora Schwegel, Christoph Strohhofer, Ewald Kolesnik, et al.
American Heart Journal|January 19, 2022
Ertugliflozin to reduce arrhythmic burden in ICD/CRT patients (ERASe-trial) - A phase III studyDirk von Lewinski, Norbert J Tripolt, Harald Sourij, et al.
American Heart Journal|January 6, 2020
Impact of EMpagliflozin on cardiac function and biomarkers of heart failure in patients with acute MYocardial infarction-The EMMY trialNorbert J Tripolt, Ewald Kolesnik, Peter N Pferschy, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
The New England Journal of Medicine|November 18, 2010
Drug-eluting versus bare-metal stents in large coronary arteriesChristoph Kaiser, Soeren Galatius, Paul Erne, et al.
The American Journal of Cardiology|November 7, 2017
In-Hospital Outcome Comparing Bivalirudin to Heparin in Real-World Primary Percutaneous Coronary InterventionMatthias Hasun, Jakob Dörler, Michael Edlinger, et al.
Wiener Klinische Wochenschrift|February 20, 2020
Heart failure disease management programs in Austria 2019 : A systematic survey of the Heart Failure Working Group and the Working Group for Cardiological Assistance and Care Personnel of the Austrian Society of CardiologyGerhard Poelzl, Bettina Fetz, Johann Altenberger, et al.
American Heart Journal|August 9, 2024
A randomized comparison of the treatment sequence of percutaneous coronary intervention and transcatheter aortic valve implantation: Rationale and design of the TAVI PCI trialBarbara E Stähli, Axel Linke, Dirk Westermann, et al.
Journal of Clinical Medicine|October 14, 2022
Dutogliptin in Combination with Filgrastim in Early Recovery Post-Myocardial Infarction-The REC-DUT-002 TrialDirk von Lewinski, Martin Benedikt, Hannes Alber, et al.
International Journal of Cardiology|July 16, 2013
Heart rate at discharge and long-term prognosis following percutaneous coronary intervention in stable and acute coronary syndromes--results from the BASKET PROVE trialMagnus Thorsten Jensen, Christoph Kaiser, Karl Erik Sandsten, et al.
Plos One|January 16, 2019
Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE IIRaban V Jeger, Matthias Pfisterer, Deborah R Vogt, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 19, 2024
Impact of empagliflozin on cardiac structure and function assessed by echocardiography after myocardial infarction: a post-hoc sub-analysis of the emmy trialNora Schwegel, Christoph Strohhofer, Ewald Kolesnik, et al.
American Heart Journal|January 19, 2022
Ertugliflozin to reduce arrhythmic burden in ICD/CRT patients (ERASe-trial) - A phase III studyDirk von Lewinski, Norbert J Tripolt, Harald Sourij, et al.
American Heart Journal|January 6, 2020
Impact of EMpagliflozin on cardiac function and biomarkers of heart failure in patients with acute MYocardial infarction-The EMMY trialNorbert J Tripolt, Ewald Kolesnik, Peter N Pferschy, et al.
Pageof 5